查看更多>>摘要:The health significance of triglyceride-rich lipoproteins,also known as remnant cholesterol,has been increasingly recognized.However,evidence of their associations with cause-specific mortality in the gen-eral population was previously insufficient.To explore these associations and their heterogeneities across subgroups,a prospective cohort study was conducted including 3,403,414 community-based participants from ChinaHEART,an ongoing government-funded public health program throughout China,from November 2014 through December 2022.The study assessed mortality risk of all-cause mortality,cardio-vascular disease(CVD)mortality(including mortality from ischemic heart diseases(IHD),ischemic stroke(IS),and hemorrhagic stroke(HS),separately),and cancer mortality(including lung cancer,stomach can-cer,and liver cancer,separately).During the 4-year follow-up,23,646 individuals died from CVD(includ-ing 8807 from IHD,3067 from IS,and 5190 from HS),and 20,318 from cancer(including 6208 from lung cancer,3013 from liver cancer,and 2174 from stomach cancer).Compared with individuals with remnant cholesterol<17.9 mg/dL,multivariable-adjusted mortality hazard ratios(HRs)for individuals with rem-nant cholesterol≥27.7mg/dL were 1.03(1.00-1.05)for all-cause mortality,1.17(1.12-1.21)for CVD(1.19(1.12-1.27)for IHD mortality,and 1.22(1.09-1.36)for IS mortality),and 0.90(0.87-0.94)for all-cancer mortality(0.94(0.87-1.02)for lung cancer,0.59(0.53-0.66)for liver cancer,and 0.73(0.64-0.83)for stomach cancer).In summary,this study revealed a correlation between increased remnant cholesterol levels and an elevated risk of cardiovascular disease mortality,as well as a reduced risk of mortality for certain types of cancer.